Statins use and prostate cancer mortality

Eur J Cancer. 2020 Jan:124:219-220. doi: 10.1016/j.ejca.2019.09.017. Epub 2019 Oct 31.

Authors

Shih-Wei Lai¹, Yu-Hung Kuo², Kuan-Fu Liao³

Affiliations

¹ College of Medicine, China Medical University, Taichung, Taiwan; Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.
² Department of Research, Taichung Tzu Chi Hospital, Taichung, Taiwan.
³ College of Medicine, Tzu Chi University, Hualien, Taiwan; Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan. Electronic address: kuanfuliaog@gmail.com.

PMID: 31677944
DOI: 10.1016/j.ejca.2019.09.017

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Incidence
Lipids
Male
Prostatic Neoplasms*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipids